Home Ingredients AB-Fortis® (Microencapsulated Iron — Frutarom)
Energy

AB-Fortis® (Microencapsulated Iron — Frutarom)

Evidence Level
Moderate
1 Clinical Trial
5 Documented Benefits
3/5 Evidence Score

AB-Fortis® is a microencapsulated form OF iron developed by Frutarom Health (now IFF) — designed to fortify foods with iron without changing appearance, palatability, or taste. Distinguished by encapsulation technology that addresses iron's primary fortification challenges (metallic taste, color changes, GI side effects). Used for: iron deficiency replacement, anemia adjunct, food fortification, supplementation with improved palatability.

Studied Dose Per AB-Fortis product specification (typical 8-18 mg elemental iron/day)
Active Compound Microencapsulated iron

Benefits

Iron Deficiency Replacement

Iron is essential for hemoglobin synthesis, oxygen transport, energy metabolism. AB-Fortis provides bioavailable iron for deficiency replacement.

Supported by Trial 1

Improved Palatability

Encapsulation eliminates metallic taste of standard iron supplements — major improvement; particularly relevant for prenatal vitamins, multivitamins, pediatric formulations.

Supported by Trial 1

Food Fortification Without Sensory Changes

Suitable for fortifying foods (cereals, baked goods, beverages) without changing appearance, taste, or color.

Supported by Trial 1

Reduced Oxidation

Encapsulation reduces iron oxidation in food matrices and during digestion.

Supported by Trial 1

Reduced GI Side Effects

May reduce iron-related GI side effects (constipation, nausea) common with standard iron.

Supported by Trial 1

Mechanism of action

1

Iron Hemoglobin Function

Iron is essential cofactor in hemoglobin and myoglobin; deficiency causes microcytic anemia.

2

Iron Energy Metabolism

Iron is cofactor for cytochromes in mitochondrial electron transport — relevant to energy production.

3

Microencapsulation

Protects iron through GI tract; releases at appropriate location for absorption; reduces interaction with food matrix.

Clinical trials

1
AB-Fortis Bioavailability Studies — Frutarom

Frutarom clinical evaluation of AB-Fortis bioavailability and efficacy.

Adults including iron-deficient populations.

Bioavailability suitable for iron deficiency replacement; improved palatability vs unencapsulated iron.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated; encapsulation reduces standard iron side effects.
Mild GI distress, constipation possible (less than standard iron).
Dark stool (normal with iron).
Iron overload concern — never supplement iron without confirmed need due to hemochromatosis risk.

Important Drug interactions

Levothyroxine — iron reduces absorption; separate by 4 hours.
Fluoroquinolones, tetracyclines — iron reduces absorption; separate by 2 hours.
Calcium supplements — calcium reduces iron absorption; separate timing.
Zinc supplements — competition for absorption; separate timing.
PPIs / antacids — reduced gastric acid impairs iron absorption.
Vitamin C — enhances non-heme iron absorption (positive interaction).
Pregnancy — iron deficiency common; supplementation often appropriate; consult prenatal care.
Hemochromatosis — avoid iron supplementation in this condition.

Featured in these supplement guides

Low Iron & Anemia Support→

More Energy Ingredients

Energy
Caffeine
Caffeine, a natural stimulant found in coffee, tea, and other plants, is commonly suppleme…
Energy
Iron
Iron is an essential mineral best known for its central role in making hemoglobin, the pro…
Energy
Pantothenic Acid
Pantothenic acid (vitamin B5) is an essential water-soluble vitamin needed to make coenzym…
Energy
Riboflavin
Riboflavin (vitamin B2) is an essential water-soluble vitamin central to energy production…

Explore Other Ingredients

Cognitive
Vitamin B12
Vitamin B12, also known as cobalamin, is a water-soluble vitamin commonly supplemented as…
Energy
NMN (Nicotinamide Mononucleotide)
NMN (nicotinamide mononucleotide) is a precursor that the body uses to make NAD+, a coenzy…
Athletic Performance
Cordyceps
Cordyceps is a medicinal mushroom traditionally prized as an energy and vitality tonic, po…

Frequently asked questions about AB-Fortis® (Microencapsulated Iron — Frutarom)

What is AB-Fortis?

AB-Fortis® is a microencapsulated form OF iron developed by Frutarom Health (now IFF) — designed to fortify foods with iron without changing appearance, palatability, or taste.

What is AB-Fortis used for?

AB-Fortis is researched primarily for Energy. Iron is essential for hemoglobin synthesis, oxygen transport, energy metabolism. AB-Fortis provides bioavailable iron for deficiency replacement.

What is the recommended dosage of AB-Fortis?

The clinically studied dose is Per AB-Fortis product specification (typical 8-18 mg elemental iron/day) Always follow the product label and check with a healthcare provider for personal advice.

Is AB-Fortis safe, and does it have side effects?

For most healthy adults, AB-Fortis is well tolerated at studied doses. Reported effects can include: Generally well-tolerated; encapsulation reduces standard iron side effects. Mild GI distress, constipation possible (less than standard iron). It may also interact with some medications. AB-Fortis is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does AB-Fortis interact with any medications?

Possible interactions include: Levothyroxine — iron reduces absorption; separate by 4 hours. Fluoroquinolones, tetracyclines — iron reduces absorption; separate by 2 hours. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for AB-Fortis?

NutraSmarts rates the evidence for AB-Fortis as Moderate (3 out of 5). It is backed by 1 clinical trial and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Mehansho H Iron fortification technology development: new approaches The Journal of Nutrition. 2006;136(4):1059-63. doi: 10.1093/jn/136.4.1059.PubMedUsed to support: Review documenting encapsulation, chelation, and redox-modulation approaches to iron fortification showing that these methods eliminate detrimental effects on taste, color, and product stability while maintaining bioavailability and reducing iron deficiency anemia in human intervention trials. Supports Improved Palatability, Food Fortification Without Sensory Changes, and Reduced Oxidation benefits. Study covers the compound class/technology rather than the AB-Fortis brand specifically.
  2. Kongkachuichai R, Kounhawej A, Chavasit V, Charoensiri R Effects of various iron fortificants on sensory acceptability and shelf-life stability of instant noodles Food and Nutrition Bulletin. 2007;28(2):165-72. doi: 10.1177/156482650702800205.PubMedUsed to support: Comparative study of iron fortification forms in food showing that iron compound choice critically affects sensory acceptability and color stability. Supports the Food Fortification Without Sensory Changes benefit by providing evidence for the importance of encapsulation in food-grade iron applications. Study is on iron compounds generally, not the AB-Fortis brand.
  3. Gotelli CA, Gotelli MJ, Boccio JR, Zubillaga MB, Caro RA, García del Río H, Weill R Bioavailability of microencapsulated ferrous sulfate in fluid milk studies in human beings Acta Physiologica, Pharmacologica et Therapeutica Latinoamericana. 1996;46(4):239-45..PubMedUsed to support: Human bioavailability study (n=29) showing microencapsulated ferrous sulfate (soy-lecithin-coated, SFE-171) in fortified milk achieved 10.2% average iron absorption without affecting sensory qualities. Supports Iron Deficiency Replacement and Improved Palatability benefits with human evidence. Study is on microencapsulated ferrous sulfate as a compound class, not the AB-Fortis brand specifically.